PubMed

Jab1 is a target of EGFR signaling in ERalpha-negative breast cancer.

Wang J, Barnes RO, West NR, Olson M, Chu JE, Watson PH.

Breast Cancer Res. 2008;10(3):R51. Epub 2008 Jun 6.PMID: 18534028 [PubMed - indexed for MEDLINE]Related articlesFree article

The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer.

Emberley ED, Niu Y, Curtis L, Troup S, Mandal SK, Myers JN, Gibson SB, Murphy LC, Watson PH.

Cancer Res. 2005 Jul 1;65(13):5696-702.PMID: 15994944 [PubMed - indexed for MEDLINE]Related articlesFree article

Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.

Creighton CJ, Hilger AM, Murthy S, Rae JM, Chinnaiyan AM, El-Ashry D.

Cancer Res. 2006 Apr 1;66(7):3903-11.PMID: 16585219 [PubMed - indexed for MEDLINE]Related articlesFree article

The role of miR-206 in the epidermal growth factor (EGF) induced repression of estrogen receptor-alpha (ERalpha) signaling and a luminal phenotype in MCF-7 breast cancer cells.

Adams BD, Cowee DM, White BA.

Mol Endocrinol. 2009 Aug;23(8):1215-30. Epub 2009 May 7.PMID: 19423651 [PubMed - indexed for MEDLINE]Related articles

Estrogen negatively regulates epidermal growth factor (EGF)-mediated signal transducer and activator of transcription 5 signaling in human EGF family receptor-overexpressing breast cancer cells.

Boerner JL, Gibson MA, Fox EM, Posner ED, Parsons SJ, Silva CM, Shupnik MA.

Mol Endocrinol. 2005 Nov;19(11):2660-70. Epub 2005 Jun 23.PMID: 15976008 [PubMed - indexed for MEDLINE]Related articlesFree article

Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.

Huang Y, Li X, Jiang J, Frank SJ.

Oncogene. 2006 Dec 7;25(58):7565-76. Epub 2006 Jun 19.PMID: 16785991 [PubMed - indexed for MEDLINE]Related articles

Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.

Schlange T, Matsuda Y, Lienhard S, Huber A, Hynes NE.

Breast Cancer Res. 2007;9(5):R63.PMID: 17897439 [PubMed - indexed for MEDLINE]Related articlesFree article

Epidermal growth factor induces WISP-2/CCN5 expression in estrogen receptor-alpha-positive breast tumor cells through multiple molecular cross-talks.

Banerjee S, Sengupta K, Saxena NK, Dhar K, Banerjee SK.

Mol Cancer Res. 2005 Mar;3(3):151-62.PMID: 15798095 [PubMed - indexed for MEDLINE]Related articlesFree article

Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells.

Song RX, Zhang Z, Chen Y, Bao Y, Santen RJ.

Endocrinology. 2007 Aug;148(8):4091-101. Epub 2007 May 24.PMID: 17525128 [PubMed - indexed for MEDLINE]Related articlesFree article

TOB1 is regulated by EGF-dependent HER2 and EGFR signaling, is highly phosphorylated, and indicates poor prognosis in node-negative breast cancer.

Helms MW, Kemming D, Contag CH, Pospisil H, Bartkowiak K, Wang A, Chang SY, Buerger H, Brandt BH.

Cancer Res. 2009 Jun 15;69(12):5049-56. Epub 2009 Jun 2.PMID: 19491269 [PubMed - indexed for MEDLINE]Related articles

Long-term treatment with tamoxifen facilitates translocation of estrogen receptor alpha out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer cells.

Fan P, Wang J, Santen RJ, Yue W.

Cancer Res. 2007 Feb 1;67(3):1352-60.PMID: 17283173 [PubMed - indexed for MEDLINE]Related articlesFree article

Distinct mechanisms mediate the initial and sustained phases of cell migration in epidermal growth factor receptor-overexpressing cells.

Kruger JS, Reddy KB.

Mol Cancer Res. 2003 Sep;1(11):801-9.PMID: 14517342 [PubMed - indexed for MEDLINE]Related articlesFree article

Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells.

Fox EM, Bernaciak TM, Wen J, Weaver AM, Shupnik MA, Silva CM.

Mol Endocrinol. 2008 Aug;22(8):1781-96. Epub 2008 Jun 11.PMID: 18550772 [PubMed - indexed for MEDLINE]Related articlesFree article

EGFR genomic gain and aberrant pathway signaling in pancreatic cancer patients.

Tzeng CW, Frolov A, Frolova N, Jhala NC, Howard JH, Vickers SM, Buchsbaum DJ, Heslin MJ, Arnoletti JP.

J Surg Res. 2007 Nov;143(1):20-6.PMID: 17950068 [PubMed - indexed for MEDLINE]Related articles

Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer.

Esteva FJ, Sahin AA, Rassidakis GZ, Yuan LX, Smith TL, Yang Y, Gilcrease MZ, Cristofanilli M, Nahta R, Pusztai L, Claret FX.

Clin Cancer Res. 2003 Nov 15;9(15):5652-9.PMID: 14654548 [PubMed - indexed for MEDLINE]Related articlesFree article

Inhibition of histone deacetylase suppresses EGF signaling pathways by destabilizing EGFR mRNA in ER-negative human breast cancer cells.

Zhou Q, Shaw PG, Davidson NE.

Breast Cancer Res Treat. 2009 Sep;117(2):443-51. Epub 2008 Aug 6.PMID: 18683042 [PubMed - indexed for MEDLINE]Related articles

Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer.

Oliveras-Ferraros C, Vazquez-Martin A, López-Bonet E, Martín-Castillo B, Del Barco S, Brunet J, Menendez JA.

Int J Oncol. 2008 Dec;33(6):1165-76.PMID: 19020749 [PubMed - indexed for MEDLINE]Related articles

EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization.

Lo HW, Hsu SC, Hung MC.

Breast Cancer Res Treat. 2006 Feb;95(3):211-8. Review.PMID: 16261406 [PubMed - indexed for MEDLINE]Related articles

G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.

Albanito L, Madeo A, Lappano R, Vivacqua A, Rago V, Carpino A, Oprea TI, Prossnitz ER, Musti AM, Andò S, Maggiolini M.

Cancer Res. 2007 Feb 15;67(4):1859-66.PMID: 17308128 [PubMed - indexed for MEDLINE]Related articlesFree article

S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast.

Emberley ED, Alowami S, Snell L, Murphy LC, Watson PH.

Breast Cancer Res. 2004;6(4):R308-15. Epub 2004 Apr 26.PMID: 15217497 [PubMed - indexed for MEDLINE]Related articlesFree article